-
Sanofi shut down French plant over "astronomical" emission levels
pharmafile
July 17, 2018
Sanofi announced yesterday that they have stopped production at their plant in the French Pyrenees following complaints that the factory has been “sending astronomical quantities of pollutants into the air."
-
Sanofi to sell generics unit for 1.9 billion Euros
pharmatimes
July 17, 2018
Global investment group Advent International says it has entered into exclusive negotiations to buy Sanofi’s generics arm Zentiva for 1.9 billion Euros ($2.4 billion).
-
Deals this week: Sanofi, EBOS, Menarini Asia-Pacific Holdings
pharmaceutical-technology
July 12, 2018
Sanofi has signed an agreement with Evotec to integrate its infectious disease unit into the latter’s business.
-
Voyager Therapeutics poaches Genzyme, Sanofi executive Andre Turenne as new CEO
fiercebiotech
July 09, 2018
Four months after Voyager Therapeutics’ chief and founder Steven Paul, M.D., said he would step down to become an “executive science adviser,” the neurological disease biotech has found a new leader.
-
Sanofi invests €66m in Chinese R&D hub
pharmafile
July 06, 2018
French multinational Sanofi is investing €66 million in a tech-focused operation in China in an effort to increase efficiency and speed up the analysis of clinical trials
-
Sanofi presents positive results of long-acting insulin Toujeo
biospectrumasia
July 06, 2018
Incidence and rate of low blood sugar events were reduced with Toujeo in the first 12 weeks compared to insulin degludec, and comparable from weeks 13-24 and the full 24-week study period.
-
Sanofi opens $77 M R&D Facility in Chengdu
biospectrumasia
July 05, 2018
The new hub plans to recruit 300 pharma R&D staff by 2020.
-
Sanofi Launches Global R&D Ops in China
contractpharma
July 03, 2018
Sanofi is launching a Global R&D Operations Hub focused on digitalization and big data analysis in Chengdu, Sichuan province, China.
-
Sanofi, Advent finally shake hands on $2.2B European generics sale
fiercepharma
July 02, 2018
It’s official: Sanofi is finally ready to unload its European generics business.
-
Citing 'substantial benefit' for patients, Sanofi hiked Flublok price 12.5% last season
fiercevaccines
June 26, 2018
Amid an industrywide look into pharma's pricing, Sanofi has pledged to limit its drug price hikes to the rate of medical inflation.